Targeting the airway epithelial barrier during B.thailandensis or F. tularensis infections with corticosteroids or anti-TNF compounds may represent potential therapeutic strategies for the treatment of the pulmonary diseases caused by bacterial infections, especially melioidosis and tularemia, by limiting bacterial passage across the epithelium and inflammation. This evidence concerns the gene TNF and bacterial infectious disease.